nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS3—rheumatoid arthritis	0.17	0.509	CbGaD
Doxorubicin—NOS2—rheumatoid arthritis	0.164	0.491	CbGaD
Doxorubicin—NOS2—Dexamethasone—rheumatoid arthritis	0.0515	0.13	CbGbCtD
Doxorubicin—XDH—Azathioprine—rheumatoid arthritis	0.0454	0.114	CbGbCtD
Doxorubicin—ABCC10—Cyclosporine—rheumatoid arthritis	0.0343	0.0864	CbGbCtD
Doxorubicin—ABCC3—Cyclosporine—rheumatoid arthritis	0.0216	0.0543	CbGbCtD
Doxorubicin—ABCG2—Leflunomide—rheumatoid arthritis	0.0189	0.0477	CbGbCtD
Doxorubicin—ABCB11—Cyclosporine—rheumatoid arthritis	0.0187	0.0469	CbGbCtD
Doxorubicin—ABCC10—Methotrexate—rheumatoid arthritis	0.0182	0.0457	CbGbCtD
Doxorubicin—ABCC1—Cyclosporine—rheumatoid arthritis	0.0133	0.0333	CbGbCtD
Doxorubicin—ABCC2—Sulfasalazine—rheumatoid arthritis	0.0129	0.0326	CbGbCtD
Doxorubicin—ABCB11—Dexamethasone—rheumatoid arthritis	0.0123	0.0309	CbGbCtD
Doxorubicin—CYP1B1—Dexamethasone—rheumatoid arthritis	0.0123	0.0309	CbGbCtD
Doxorubicin—ABCG2—Sulfasalazine—rheumatoid arthritis	0.0117	0.0294	CbGbCtD
Doxorubicin—ABCC3—Methotrexate—rheumatoid arthritis	0.0114	0.0287	CbGbCtD
Doxorubicin—ABCC2—Cyclosporine—rheumatoid arthritis	0.00981	0.0247	CbGbCtD
Doxorubicin—ABCG2—Hydrocortisone—rheumatoid arthritis	0.00939	0.0236	CbGbCtD
Doxorubicin—ABCG2—Cyclosporine—rheumatoid arthritis	0.00887	0.0223	CbGbCtD
Doxorubicin—ABCC1—Methotrexate—rheumatoid arthritis	0.00701	0.0176	CbGbCtD
Doxorubicin—ABCC2—Dexamethasone—rheumatoid arthritis	0.00646	0.0163	CbGbCtD
Doxorubicin—ABCG2—Dexamethasone—rheumatoid arthritis	0.00584	0.0147	CbGbCtD
Doxorubicin—ABCB1—Methylprednisolone—rheumatoid arthritis	0.00557	0.014	CbGbCtD
Doxorubicin—ABCC2—Methotrexate—rheumatoid arthritis	0.00519	0.0131	CbGbCtD
Doxorubicin—ABCG2—Methotrexate—rheumatoid arthritis	0.00469	0.0118	CbGbCtD
Doxorubicin—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00452	0.0114	CbGbCtD
Doxorubicin—CYP2B6—Dexamethasone—rheumatoid arthritis	0.00411	0.0103	CbGbCtD
Doxorubicin—ABCB1—Betamethasone—rheumatoid arthritis	0.00362	0.00911	CbGbCtD
Doxorubicin—ABCB1—Prednisolone—rheumatoid arthritis	0.00357	0.00899	CbGbCtD
Doxorubicin—ABCB1—Hydrocortisone—rheumatoid arthritis	0.00339	0.00852	CbGbCtD
Doxorubicin—ABCB1—Prednisone—rheumatoid arthritis	0.00337	0.00849	CbGbCtD
Doxorubicin—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00334	0.00839	CbGbCtD
Doxorubicin—ABCB1—Cyclosporine—rheumatoid arthritis	0.0032	0.00805	CbGbCtD
Doxorubicin—CYP2D6—Cyclosporine—rheumatoid arthritis	0.00301	0.00758	CbGbCtD
Doxorubicin—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00253	0.00636	CbGbCtD
Doxorubicin—CYP3A4—Betamethasone—rheumatoid arthritis	0.00217	0.00546	CbGbCtD
Doxorubicin—CYP3A4—Prednisolone—rheumatoid arthritis	0.00214	0.00539	CbGbCtD
Doxorubicin—ABCB1—Dexamethasone—rheumatoid arthritis	0.00211	0.0053	CbGbCtD
Doxorubicin—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00203	0.00511	CbGbCtD
Doxorubicin—CYP3A4—Prednisone—rheumatoid arthritis	0.00202	0.00509	CbGbCtD
Doxorubicin—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00198	0.00499	CbGbCtD
Doxorubicin—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00192	0.00482	CbGbCtD
Doxorubicin—ABCB1—Methotrexate—rheumatoid arthritis	0.00169	0.00426	CbGbCtD
Doxorubicin—CBR3—parotid gland—rheumatoid arthritis	0.00137	0.0316	CbGeAlD
Doxorubicin—NOS2—tendon—rheumatoid arthritis	0.00134	0.0308	CbGeAlD
Doxorubicin—CBR3—saliva-secreting gland—rheumatoid arthritis	0.00131	0.0303	CbGeAlD
Doxorubicin—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00126	0.00317	CbGbCtD
Doxorubicin—AKR1A1—parotid gland—rheumatoid arthritis	0.00106	0.0244	CbGeAlD
Doxorubicin—AKR1A1—saliva-secreting gland—rheumatoid arthritis	0.00101	0.0234	CbGeAlD
Doxorubicin—NDUFS7—connective tissue—rheumatoid arthritis	0.000847	0.0195	CbGeAlD
Doxorubicin—CBR3—tendon—rheumatoid arthritis	0.000829	0.0191	CbGeAlD
Doxorubicin—NDUFS2—parotid gland—rheumatoid arthritis	0.000797	0.0184	CbGeAlD
Doxorubicin—NDUFS3—parotid gland—rheumatoid arthritis	0.000787	0.0182	CbGeAlD
Doxorubicin—NDUFS2—saliva-secreting gland—rheumatoid arthritis	0.000763	0.0176	CbGeAlD
Doxorubicin—NDUFS3—saliva-secreting gland—rheumatoid arthritis	0.000754	0.0174	CbGeAlD
Doxorubicin—DHCR7—parotid gland—rheumatoid arthritis	0.000748	0.0173	CbGeAlD
Doxorubicin—DHCR7—saliva-secreting gland—rheumatoid arthritis	0.000717	0.0165	CbGeAlD
Doxorubicin—NDUFS2—connective tissue—rheumatoid arthritis	0.000702	0.0162	CbGeAlD
Doxorubicin—NDUFS3—connective tissue—rheumatoid arthritis	0.000693	0.016	CbGeAlD
Doxorubicin—YWHAG—parotid gland—rheumatoid arthritis	0.000686	0.0158	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—rheumatoid arthritis	0.000681	0.0157	CbGeAlD
Doxorubicin—AKR1A1—digestive system—rheumatoid arthritis	0.000673	0.0155	CbGeAlD
Doxorubicin—YWHAG—saliva-secreting gland—rheumatoid arthritis	0.000657	0.0152	CbGeAlD
Doxorubicin—ABCC6—connective tissue—rheumatoid arthritis	0.000642	0.0148	CbGeAlD
Doxorubicin—AKR1A1—tendon—rheumatoid arthritis	0.00064	0.0148	CbGeAlD
Doxorubicin—RALBP1—parotid gland—rheumatoid arthritis	0.00062	0.0143	CbGeAlD
Doxorubicin—NDUFS7—digestive system—rheumatoid arthritis	0.000611	0.0141	CbGeAlD
Doxorubicin—YWHAG—connective tissue—rheumatoid arthritis	0.000604	0.0139	CbGeAlD
Doxorubicin—RALBP1—saliva-secreting gland—rheumatoid arthritis	0.000594	0.0137	CbGeAlD
Doxorubicin—NDUFS7—tendon—rheumatoid arthritis	0.000582	0.0134	CbGeAlD
Doxorubicin—CBR1—parotid gland—rheumatoid arthritis	0.000579	0.0133	CbGeAlD
Doxorubicin—AURKA—lymphoid tissue—rheumatoid arthritis	0.000576	0.0133	CbGeAlD
Doxorubicin—AKR1C3—parotid gland—rheumatoid arthritis	0.000572	0.0132	CbGeAlD
Doxorubicin—AURKA—digestive system—rheumatoid arthritis	0.000568	0.0131	CbGeAlD
Doxorubicin—CBR1—saliva-secreting gland—rheumatoid arthritis	0.000554	0.0128	CbGeAlD
Doxorubicin—AURKA—tendon—rheumatoid arthritis	0.000541	0.0125	CbGeAlD
Doxorubicin—NOS3—connective tissue—rheumatoid arthritis	0.000537	0.0124	CbGeAlD
Doxorubicin—POR—parotid gland—rheumatoid arthritis	0.000522	0.012	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—rheumatoid arthritis	0.000513	0.0118	CbGeAlD
Doxorubicin—NOS1—digestive system—rheumatoid arthritis	0.00051	0.0118	CbGeAlD
Doxorubicin—NDUFS2—digestive system—rheumatoid arthritis	0.000507	0.0117	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—rheumatoid arthritis	0.000507	0.0117	CbGeAlD
Doxorubicin—NDUFS3—digestive system—rheumatoid arthritis	0.0005	0.0115	CbGeAlD
Doxorubicin—POR—saliva-secreting gland—rheumatoid arthritis	0.0005	0.0115	CbGeAlD
Doxorubicin—NOS1—tendon—rheumatoid arthritis	0.000485	0.0112	CbGeAlD
Doxorubicin—NDUFS2—tendon—rheumatoid arthritis	0.000482	0.0111	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—rheumatoid arthritis	0.000481	0.0111	CbGeAlD
Doxorubicin—NDUFS3—tendon—rheumatoid arthritis	0.000476	0.011	CbGeAlD
Doxorubicin—DHCR7—digestive system—rheumatoid arthritis	0.000476	0.011	CbGeAlD
Doxorubicin—NQO1—parotid gland—rheumatoid arthritis	0.000464	0.0107	CbGeAlD
Doxorubicin—NQO1—saliva-secreting gland—rheumatoid arthritis	0.000444	0.0102	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—rheumatoid arthritis	0.000442	0.0102	CbGeAlD
Doxorubicin—YWHAG—digestive system—rheumatoid arthritis	0.000436	0.0101	CbGeAlD
Doxorubicin—XDH—digestive system—rheumatoid arthritis	0.000426	0.00981	CbGeAlD
Doxorubicin—ABCB11—digestive system—rheumatoid arthritis	0.000416	0.00959	CbGeAlD
Doxorubicin—YWHAG—tendon—rheumatoid arthritis	0.000415	0.00958	CbGeAlD
Doxorubicin—ABCC10—parotid gland—rheumatoid arthritis	0.000414	0.00955	CbGeAlD
Doxorubicin—NQO1—connective tissue—rheumatoid arthritis	0.000408	0.00941	CbGeAlD
Doxorubicin—ABCC10—saliva-secreting gland—rheumatoid arthritis	0.000397	0.00915	CbGeAlD
Doxorubicin—RALBP1—digestive system—rheumatoid arthritis	0.000394	0.00909	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—rheumatoid arthritis	0.000392	0.00905	CbGeAlD
Doxorubicin—NOS3—digestive system—rheumatoid arthritis	0.000388	0.00894	CbGeAlD
Doxorubicin—RALBP1—tendon—rheumatoid arthritis	0.000375	0.00865	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—rheumatoid arthritis	0.000372	0.00859	CbGeAlD
Doxorubicin—NOS3—tendon—rheumatoid arthritis	0.000369	0.00851	CbGeAlD
Doxorubicin—CBR1—digestive system—rheumatoid arthritis	0.000368	0.00848	CbGeAlD
Doxorubicin—CBR1—tendon—rheumatoid arthritis	0.00035	0.00807	CbGeAlD
Doxorubicin—AURKA—Calcipotriol—Ergocalciferol—rheumatoid arthritis	0.000347	0.128	CbGdCrCtD
Doxorubicin—AKR1C3—tendon—rheumatoid arthritis	0.000346	0.00797	CbGeAlD
Doxorubicin—POR—tendon—rheumatoid arthritis	0.000316	0.00728	CbGeAlD
Doxorubicin—NQO1—digestive system—rheumatoid arthritis	0.000295	0.0068	CbGeAlD
Doxorubicin—TOP2A—tendon—rheumatoid arthritis	0.000294	0.00679	CbGeAlD
Doxorubicin—ABCC1—parotid gland—rheumatoid arthritis	0.000293	0.00676	CbGeAlD
Doxorubicin—CYP1B1—connective tissue—rheumatoid arthritis	0.000287	0.00661	CbGeAlD
Doxorubicin—NQO1—tendon—rheumatoid arthritis	0.00028	0.00647	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—rheumatoid arthritis	0.000266	0.00615	CbGeAlD
Doxorubicin—ABCC3—digestive system—rheumatoid arthritis	0.000265	0.0061	CbGeAlD
Doxorubicin—ABCC10—digestive system—rheumatoid arthritis	0.000263	0.00607	CbGeAlD
Doxorubicin—ABCC10—tendon—rheumatoid arthritis	0.000251	0.00578	CbGeAlD
Doxorubicin—ABCG2—parotid gland—rheumatoid arthritis	0.000242	0.00559	CbGeAlD
Doxorubicin—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000232	0.00536	CbGeAlD
Doxorubicin—ABCC2—digestive system—rheumatoid arthritis	0.000211	0.00487	CbGeAlD
Doxorubicin—CYP1B1—lymphoid tissue—rheumatoid arthritis	0.00021	0.00483	CbGeAlD
Doxorubicin—CYP1B1—digestive system—rheumatoid arthritis	0.000207	0.00477	CbGeAlD
Doxorubicin—ABCC2—tendon—rheumatoid arthritis	0.000201	0.00464	CbGeAlD
Doxorubicin—CYP1B1—tendon—rheumatoid arthritis	0.000197	0.00454	CbGeAlD
Doxorubicin—ABCC1—tendon—rheumatoid arthritis	0.000177	0.00409	CbGeAlD
Doxorubicin—CYP2B6—lymphoid tissue—rheumatoid arthritis	0.000144	0.00332	CbGeAlD
Doxorubicin—CYP2B6—digestive system—rheumatoid arthritis	0.000142	0.00328	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Hydrocortisone—rheumatoid arthritis	0.000121	0.0446	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Methylprednisolone—rheumatoid arthritis	0.000114	0.042	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Betamethasone—rheumatoid arthritis	0.000112	0.0414	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Dexamethasone—rheumatoid arthritis	0.000112	0.0414	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Triamcinolone—rheumatoid arthritis	0.00011	0.0404	CbGdCrCtD
Doxorubicin—CYP3A4—digestive system—rheumatoid arthritis	0.000107	0.00248	CbGeAlD
Doxorubicin—CYP2D6—digestive system—rheumatoid arthritis	0.000106	0.00244	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Prednisone—rheumatoid arthritis	0.000104	0.0384	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Prednisolone—rheumatoid arthritis	0.000102	0.0375	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Hydrocortisone—rheumatoid arthritis	0.0001	0.0368	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Methylprednisolone—rheumatoid arthritis	9.44e-05	0.0347	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Betamethasone—rheumatoid arthritis	9.3e-05	0.0342	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Dexamethasone—rheumatoid arthritis	9.3e-05	0.0342	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Methylprednisolone—rheumatoid arthritis	8.68e-05	0.0319	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisone—rheumatoid arthritis	8.62e-05	0.0317	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Dexamethasone—rheumatoid arthritis	8.54e-05	0.0314	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Betamethasone—rheumatoid arthritis	8.54e-05	0.0314	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisolone—rheumatoid arthritis	8.41e-05	0.0309	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Triamcinolone—rheumatoid arthritis	8.35e-05	0.0307	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Prednisolone—rheumatoid arthritis	7.73e-05	0.0284	CbGdCrCtD
Doxorubicin—ABCB1—lymphoid tissue—rheumatoid arthritis	7.69e-05	0.00177	CbGeAlD
Doxorubicin—ABCB1—digestive system—rheumatoid arthritis	7.6e-05	0.00175	CbGeAlD
Doxorubicin—CBR3—Dexamethasone—Hydrocortisone—rheumatoid arthritis	4.95e-05	0.0182	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Hydrocortisone—rheumatoid arthritis	4.95e-05	0.0182	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Methylprednisolone—rheumatoid arthritis	4.67e-05	0.0172	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Methylprednisolone—rheumatoid arthritis	4.67e-05	0.0172	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Betamethasone—rheumatoid arthritis	4.59e-05	0.0169	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Dexamethasone—rheumatoid arthritis	4.59e-05	0.0169	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Triamcinolone—rheumatoid arthritis	4.49e-05	0.0165	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Triamcinolone—rheumatoid arthritis	4.49e-05	0.0165	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisone—rheumatoid arthritis	4.26e-05	0.0157	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisone—rheumatoid arthritis	4.26e-05	0.0157	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisolone—rheumatoid arthritis	4.16e-05	0.0153	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisolone—rheumatoid arthritis	4.16e-05	0.0153	CbGdCrCtD
Doxorubicin—Pharyngitis—Methotrexate—rheumatoid arthritis	3.02e-05	0.000231	CcSEcCtD
Doxorubicin—Nausea—Leflunomide—rheumatoid arthritis	3.01e-05	0.000231	CcSEcCtD
Doxorubicin—Urinary tract disorder—Methotrexate—rheumatoid arthritis	3.01e-05	0.00023	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	3e-05	0.00023	CcSEcCtD
Doxorubicin—Fatigue—Hydrocortisone—rheumatoid arthritis	3e-05	0.00023	CcSEcCtD
Doxorubicin—Vision blurred—Prednisone—rheumatoid arthritis	2.99e-05	0.000229	CcSEcCtD
Doxorubicin—Urethral disorder—Methotrexate—rheumatoid arthritis	2.98e-05	0.000229	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	2.98e-05	0.000229	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	2.98e-05	0.000228	CcSEcCtD
Doxorubicin—Pain—Hydrocortisone—rheumatoid arthritis	2.97e-05	0.000228	CcSEcCtD
Doxorubicin—Anaphylactic shock—Betamethasone—rheumatoid arthritis	2.97e-05	0.000228	CcSEcCtD
Doxorubicin—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	2.97e-05	0.000228	CcSEcCtD
Doxorubicin—Oedema—Dexamethasone—rheumatoid arthritis	2.97e-05	0.000228	CcSEcCtD
Doxorubicin—Oedema—Betamethasone—rheumatoid arthritis	2.97e-05	0.000228	CcSEcCtD
Doxorubicin—Insomnia—Triamcinolone—rheumatoid arthritis	2.96e-05	0.000227	CcSEcCtD
Doxorubicin—Insomnia—Methylprednisolone—rheumatoid arthritis	2.95e-05	0.000226	CcSEcCtD
Doxorubicin—Infection—Dexamethasone—rheumatoid arthritis	2.95e-05	0.000226	CcSEcCtD
Doxorubicin—Infection—Betamethasone—rheumatoid arthritis	2.95e-05	0.000226	CcSEcCtD
Doxorubicin—Ill-defined disorder—Prednisone—rheumatoid arthritis	2.94e-05	0.000225	CcSEcCtD
Doxorubicin—Paraesthesia—Triamcinolone—rheumatoid arthritis	2.94e-05	0.000225	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisolone—rheumatoid arthritis	2.93e-05	0.000225	CcSEcCtD
Doxorubicin—Paraesthesia—Methylprednisolone—rheumatoid arthritis	2.93e-05	0.000225	CcSEcCtD
Doxorubicin—Visual impairment—Methotrexate—rheumatoid arthritis	2.93e-05	0.000225	CcSEcCtD
Doxorubicin—Anaemia—Prednisone—rheumatoid arthritis	2.93e-05	0.000224	CcSEcCtD
Doxorubicin—Shock—Betamethasone—rheumatoid arthritis	2.92e-05	0.000224	CcSEcCtD
Doxorubicin—Shock—Dexamethasone—rheumatoid arthritis	2.92e-05	0.000224	CcSEcCtD
Doxorubicin—Dyspnoea—Triamcinolone—rheumatoid arthritis	2.92e-05	0.000224	CcSEcCtD
Doxorubicin—Nervous system disorder—Betamethasone—rheumatoid arthritis	2.91e-05	0.000223	CcSEcCtD
Doxorubicin—Nervous system disorder—Dexamethasone—rheumatoid arthritis	2.91e-05	0.000223	CcSEcCtD
Doxorubicin—Agitation—Prednisone—rheumatoid arthritis	2.91e-05	0.000223	CcSEcCtD
Doxorubicin—Thrombocytopenia—Betamethasone—rheumatoid arthritis	2.91e-05	0.000223	CcSEcCtD
Doxorubicin—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	2.91e-05	0.000223	CcSEcCtD
Doxorubicin—Tachycardia—Dexamethasone—rheumatoid arthritis	2.9e-05	0.000222	CcSEcCtD
Doxorubicin—Tachycardia—Betamethasone—rheumatoid arthritis	2.9e-05	0.000222	CcSEcCtD
Doxorubicin—Hypersensitivity—Cyclosporine—rheumatoid arthritis	2.88e-05	0.000221	CcSEcCtD
Doxorubicin—Dyspepsia—Triamcinolone—rheumatoid arthritis	2.88e-05	0.000221	CcSEcCtD
Doxorubicin—Erythema multiforme—Methotrexate—rheumatoid arthritis	2.88e-05	0.00022	CcSEcCtD
Doxorubicin—Dyspepsia—Methylprednisolone—rheumatoid arthritis	2.88e-05	0.00022	CcSEcCtD
Doxorubicin—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	2.87e-05	0.00022	CcSEcCtD
Doxorubicin—Hyperhidrosis—Betamethasone—rheumatoid arthritis	2.87e-05	0.00022	CcSEcCtD
Doxorubicin—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	2.87e-05	0.00022	CcSEcCtD
Doxorubicin—Malaise—Prednisone—rheumatoid arthritis	2.86e-05	0.000219	CcSEcCtD
Doxorubicin—Vertigo—Prednisone—rheumatoid arthritis	2.85e-05	0.000218	CcSEcCtD
Doxorubicin—Eye disorder—Methotrexate—rheumatoid arthritis	2.84e-05	0.000218	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	2.84e-05	0.000218	CcSEcCtD
Doxorubicin—Syncope—Prednisone—rheumatoid arthritis	2.84e-05	0.000218	CcSEcCtD
Doxorubicin—Tinnitus—Methotrexate—rheumatoid arthritis	2.84e-05	0.000217	CcSEcCtD
Doxorubicin—Anorexia—Betamethasone—rheumatoid arthritis	2.83e-05	0.000217	CcSEcCtD
Doxorubicin—Anorexia—Dexamethasone—rheumatoid arthritis	2.83e-05	0.000217	CcSEcCtD
Doxorubicin—Urticaria—Prednisolone—rheumatoid arthritis	2.83e-05	0.000217	CcSEcCtD
Doxorubicin—Cardiac disorder—Methotrexate—rheumatoid arthritis	2.82e-05	0.000216	CcSEcCtD
Doxorubicin—Fatigue—Triamcinolone—rheumatoid arthritis	2.82e-05	0.000216	CcSEcCtD
Doxorubicin—Fatigue—Methylprednisolone—rheumatoid arthritis	2.82e-05	0.000216	CcSEcCtD
Doxorubicin—Asthenia—Cyclosporine—rheumatoid arthritis	2.81e-05	0.000215	CcSEcCtD
Doxorubicin—Pain—Triamcinolone—rheumatoid arthritis	2.8e-05	0.000215	CcSEcCtD
Doxorubicin—Loss of consciousness—Prednisone—rheumatoid arthritis	2.79e-05	0.000213	CcSEcCtD
Doxorubicin—Hypotension—Dexamethasone—rheumatoid arthritis	2.78e-05	0.000213	CcSEcCtD
Doxorubicin—Hypotension—Betamethasone—rheumatoid arthritis	2.78e-05	0.000213	CcSEcCtD
Doxorubicin—Pruritus—Cyclosporine—rheumatoid arthritis	2.77e-05	0.000212	CcSEcCtD
Doxorubicin—Urticaria—Hydrocortisone—rheumatoid arthritis	2.76e-05	0.000212	CcSEcCtD
Doxorubicin—Angiopathy—Methotrexate—rheumatoid arthritis	2.76e-05	0.000212	CcSEcCtD
Doxorubicin—Immune system disorder—Methotrexate—rheumatoid arthritis	2.75e-05	0.000211	CcSEcCtD
Doxorubicin—Body temperature increased—Hydrocortisone—rheumatoid arthritis	2.75e-05	0.000211	CcSEcCtD
Doxorubicin—Abdominal pain—Hydrocortisone—rheumatoid arthritis	2.75e-05	0.000211	CcSEcCtD
Doxorubicin—Convulsion—Prednisone—rheumatoid arthritis	2.75e-05	0.00021	CcSEcCtD
Doxorubicin—Mediastinal disorder—Methotrexate—rheumatoid arthritis	2.74e-05	0.00021	CcSEcCtD
Doxorubicin—Hypertension—Prednisone—rheumatoid arthritis	2.74e-05	0.00021	CcSEcCtD
Doxorubicin—Chills—Methotrexate—rheumatoid arthritis	2.73e-05	0.000209	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	2.71e-05	0.000207	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	2.71e-05	0.000207	CcSEcCtD
Doxorubicin—Arthralgia—Prednisone—rheumatoid arthritis	2.7e-05	0.000207	CcSEcCtD
Doxorubicin—Myalgia—Prednisone—rheumatoid arthritis	2.7e-05	0.000207	CcSEcCtD
Doxorubicin—Feeling abnormal—Triamcinolone—rheumatoid arthritis	2.7e-05	0.000207	CcSEcCtD
Doxorubicin—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	2.69e-05	0.000206	CcSEcCtD
Doxorubicin—Anxiety—Prednisone—rheumatoid arthritis	2.69e-05	0.000206	CcSEcCtD
Doxorubicin—Alopecia—Methotrexate—rheumatoid arthritis	2.69e-05	0.000206	CcSEcCtD
Doxorubicin—Insomnia—Dexamethasone—rheumatoid arthritis	2.69e-05	0.000206	CcSEcCtD
Doxorubicin—Insomnia—Betamethasone—rheumatoid arthritis	2.69e-05	0.000206	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	2.68e-05	0.000205	CcSEcCtD
Doxorubicin—Diarrhoea—Cyclosporine—rheumatoid arthritis	2.68e-05	0.000205	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.67e-05	0.000205	CcSEcCtD
Doxorubicin—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.67e-05	0.000204	CcSEcCtD
Doxorubicin—Paraesthesia—Betamethasone—rheumatoid arthritis	2.67e-05	0.000204	CcSEcCtD
Doxorubicin—Discomfort—Prednisone—rheumatoid arthritis	2.67e-05	0.000204	CcSEcCtD
Doxorubicin—Mental disorder—Methotrexate—rheumatoid arthritis	2.67e-05	0.000204	CcSEcCtD
Doxorubicin—Erythema—Methotrexate—rheumatoid arthritis	2.65e-05	0.000203	CcSEcCtD
Doxorubicin—Malnutrition—Methotrexate—rheumatoid arthritis	2.65e-05	0.000203	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisolone—rheumatoid arthritis	2.62e-05	0.000201	CcSEcCtD
Doxorubicin—Dyspepsia—Betamethasone—rheumatoid arthritis	2.61e-05	0.0002	CcSEcCtD
Doxorubicin—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.61e-05	0.0002	CcSEcCtD
Doxorubicin—Urticaria—Triamcinolone—rheumatoid arthritis	2.6e-05	0.000199	CcSEcCtD
Doxorubicin—Urticaria—Methylprednisolone—rheumatoid arthritis	2.59e-05	0.000199	CcSEcCtD
Doxorubicin—Dysgeusia—Methotrexate—rheumatoid arthritis	2.59e-05	0.000199	CcSEcCtD
Doxorubicin—Body temperature increased—Triamcinolone—rheumatoid arthritis	2.59e-05	0.000198	CcSEcCtD
Doxorubicin—Dizziness—Cyclosporine—rheumatoid arthritis	2.59e-05	0.000198	CcSEcCtD
Doxorubicin—Anaphylactic shock—Prednisone—rheumatoid arthritis	2.59e-05	0.000198	CcSEcCtD
Doxorubicin—Oedema—Prednisone—rheumatoid arthritis	2.59e-05	0.000198	CcSEcCtD
Doxorubicin—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.58e-05	0.000198	CcSEcCtD
Doxorubicin—Decreased appetite—Betamethasone—rheumatoid arthritis	2.58e-05	0.000198	CcSEcCtD
Doxorubicin—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.58e-05	0.000198	CcSEcCtD
Doxorubicin—Infection—Prednisone—rheumatoid arthritis	2.57e-05	0.000197	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.56e-05	0.000196	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.56e-05	0.000196	CcSEcCtD
Doxorubicin—Back pain—Methotrexate—rheumatoid arthritis	2.56e-05	0.000196	CcSEcCtD
Doxorubicin—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	2.56e-05	0.000196	CcSEcCtD
Doxorubicin—Fatigue—Dexamethasone—rheumatoid arthritis	2.56e-05	0.000196	CcSEcCtD
Doxorubicin—Fatigue—Betamethasone—rheumatoid arthritis	2.56e-05	0.000196	CcSEcCtD
Doxorubicin—Shock—Prednisone—rheumatoid arthritis	2.55e-05	0.000195	CcSEcCtD
Doxorubicin—Pain—Betamethasone—rheumatoid arthritis	2.54e-05	0.000195	CcSEcCtD
Doxorubicin—Pain—Dexamethasone—rheumatoid arthritis	2.54e-05	0.000195	CcSEcCtD
Doxorubicin—Nervous system disorder—Prednisone—rheumatoid arthritis	2.54e-05	0.000194	CcSEcCtD
Doxorubicin—Tachycardia—Prednisone—rheumatoid arthritis	2.52e-05	0.000193	CcSEcCtD
Doxorubicin—Skin disorder—Prednisone—rheumatoid arthritis	2.51e-05	0.000193	CcSEcCtD
Doxorubicin—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.5e-05	0.000192	CcSEcCtD
Doxorubicin—Vision blurred—Methotrexate—rheumatoid arthritis	2.5e-05	0.000191	CcSEcCtD
Doxorubicin—Asthenia—Hydrocortisone—rheumatoid arthritis	2.49e-05	0.000191	CcSEcCtD
Doxorubicin—Vomiting—Cyclosporine—rheumatoid arthritis	2.49e-05	0.000191	CcSEcCtD
Doxorubicin—Rash—Cyclosporine—rheumatoid arthritis	2.47e-05	0.000189	CcSEcCtD
Doxorubicin—Anorexia—Prednisone—rheumatoid arthritis	2.47e-05	0.000189	CcSEcCtD
Doxorubicin—Dermatitis—Cyclosporine—rheumatoid arthritis	2.46e-05	0.000189	CcSEcCtD
Doxorubicin—Pruritus—Hydrocortisone—rheumatoid arthritis	2.46e-05	0.000188	CcSEcCtD
Doxorubicin—Ill-defined disorder—Methotrexate—rheumatoid arthritis	2.46e-05	0.000188	CcSEcCtD
Doxorubicin—Headache—Cyclosporine—rheumatoid arthritis	2.45e-05	0.000188	CcSEcCtD
Doxorubicin—Anaemia—Methotrexate—rheumatoid arthritis	2.45e-05	0.000188	CcSEcCtD
Doxorubicin—Feeling abnormal—Betamethasone—rheumatoid arthritis	2.45e-05	0.000188	CcSEcCtD
Doxorubicin—Feeling abnormal—Dexamethasone—rheumatoid arthritis	2.45e-05	0.000188	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2.43e-05	0.000186	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2.43e-05	0.000186	CcSEcCtD
Doxorubicin—Hypersensitivity—Triamcinolone—rheumatoid arthritis	2.41e-05	0.000185	CcSEcCtD
Doxorubicin—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	2.41e-05	0.000184	CcSEcCtD
Doxorubicin—Malaise—Methotrexate—rheumatoid arthritis	2.39e-05	0.000183	CcSEcCtD
Doxorubicin—Vertigo—Methotrexate—rheumatoid arthritis	2.38e-05	0.000182	CcSEcCtD
Doxorubicin—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.38e-05	0.000182	CcSEcCtD
Doxorubicin—Leukopenia—Methotrexate—rheumatoid arthritis	2.37e-05	0.000182	CcSEcCtD
Doxorubicin—Urticaria—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000181	CcSEcCtD
Doxorubicin—Urticaria—Betamethasone—rheumatoid arthritis	2.36e-05	0.000181	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.36e-05	0.000181	CcSEcCtD
Doxorubicin—Dizziness—Prednisolone—rheumatoid arthritis	2.35e-05	0.00018	CcSEcCtD
Doxorubicin—Asthenia—Triamcinolone—rheumatoid arthritis	2.35e-05	0.00018	CcSEcCtD
Doxorubicin—Body temperature increased—Dexamethasone—rheumatoid arthritis	2.35e-05	0.00018	CcSEcCtD
Doxorubicin—Body temperature increased—Betamethasone—rheumatoid arthritis	2.35e-05	0.00018	CcSEcCtD
Doxorubicin—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.35e-05	0.00018	CcSEcCtD
Doxorubicin—Abdominal pain—Betamethasone—rheumatoid arthritis	2.35e-05	0.00018	CcSEcCtD
Doxorubicin—Asthenia—Methylprednisolone—rheumatoid arthritis	2.34e-05	0.00018	CcSEcCtD
Doxorubicin—Insomnia—Prednisone—rheumatoid arthritis	2.34e-05	0.000179	CcSEcCtD
Doxorubicin—Nausea—Cyclosporine—rheumatoid arthritis	2.32e-05	0.000178	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisone—rheumatoid arthritis	2.32e-05	0.000178	CcSEcCtD
Doxorubicin—Pruritus—Triamcinolone—rheumatoid arthritis	2.32e-05	0.000177	CcSEcCtD
Doxorubicin—Cough—Methotrexate—rheumatoid arthritis	2.31e-05	0.000177	CcSEcCtD
Doxorubicin—Pruritus—Methylprednisolone—rheumatoid arthritis	2.31e-05	0.000177	CcSEcCtD
Doxorubicin—Dizziness—Hydrocortisone—rheumatoid arthritis	2.3e-05	0.000176	CcSEcCtD
Doxorubicin—Convulsion—Methotrexate—rheumatoid arthritis	2.3e-05	0.000176	CcSEcCtD
Doxorubicin—Dyspepsia—Prednisone—rheumatoid arthritis	2.28e-05	0.000174	CcSEcCtD
Doxorubicin—Arthralgia—Methotrexate—rheumatoid arthritis	2.26e-05	0.000173	CcSEcCtD
Doxorubicin—Chest pain—Methotrexate—rheumatoid arthritis	2.26e-05	0.000173	CcSEcCtD
Doxorubicin—Myalgia—Methotrexate—rheumatoid arthritis	2.26e-05	0.000173	CcSEcCtD
Doxorubicin—Decreased appetite—Prednisone—rheumatoid arthritis	2.25e-05	0.000172	CcSEcCtD
Doxorubicin—Rash—Prednisolone—rheumatoid arthritis	2.24e-05	0.000172	CcSEcCtD
Doxorubicin—Dermatitis—Prednisolone—rheumatoid arthritis	2.24e-05	0.000172	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.24e-05	0.000172	CcSEcCtD
Doxorubicin—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.23e-05	0.000171	CcSEcCtD
Doxorubicin—Fatigue—Prednisone—rheumatoid arthritis	2.23e-05	0.000171	CcSEcCtD
Doxorubicin—Headache—Prednisolone—rheumatoid arthritis	2.23e-05	0.000171	CcSEcCtD
Doxorubicin—Discomfort—Methotrexate—rheumatoid arthritis	2.23e-05	0.000171	CcSEcCtD
Doxorubicin—Constipation—Prednisone—rheumatoid arthritis	2.21e-05	0.00017	CcSEcCtD
Doxorubicin—Vomiting—Hydrocortisone—rheumatoid arthritis	2.21e-05	0.000169	CcSEcCtD
Doxorubicin—Rash—Hydrocortisone—rheumatoid arthritis	2.19e-05	0.000168	CcSEcCtD
Doxorubicin—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.19e-05	0.000168	CcSEcCtD
Doxorubicin—Confusional state—Methotrexate—rheumatoid arthritis	2.18e-05	0.000167	CcSEcCtD
Doxorubicin—Headache—Hydrocortisone—rheumatoid arthritis	2.18e-05	0.000167	CcSEcCtD
Doxorubicin—Dizziness—Triamcinolone—rheumatoid arthritis	2.16e-05	0.000166	CcSEcCtD
Doxorubicin—Anaphylactic shock—Methotrexate—rheumatoid arthritis	2.16e-05	0.000166	CcSEcCtD
Doxorubicin—Dizziness—Methylprednisolone—rheumatoid arthritis	2.16e-05	0.000166	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Hydrocortisone—rheumatoid arthritis	2.16e-05	0.00793	CbGdCrCtD
Doxorubicin—Infection—Methotrexate—rheumatoid arthritis	2.15e-05	0.000165	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisone—rheumatoid arthritis	2.13e-05	0.000163	CcSEcCtD
Doxorubicin—Asthenia—Betamethasone—rheumatoid arthritis	2.13e-05	0.000163	CcSEcCtD
Doxorubicin—Asthenia—Dexamethasone—rheumatoid arthritis	2.13e-05	0.000163	CcSEcCtD
Doxorubicin—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.12e-05	0.000162	CcSEcCtD
Doxorubicin—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.12e-05	0.000162	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.12e-05	0.000162	CcSEcCtD
Doxorubicin—Nausea—Prednisolone—rheumatoid arthritis	2.11e-05	0.000162	CcSEcCtD
Doxorubicin—Pruritus—Dexamethasone—rheumatoid arthritis	2.1e-05	0.000161	CcSEcCtD
Doxorubicin—Pruritus—Betamethasone—rheumatoid arthritis	2.1e-05	0.000161	CcSEcCtD
Doxorubicin—Skin disorder—Methotrexate—rheumatoid arthritis	2.1e-05	0.000161	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.09e-05	0.00016	CcSEcCtD
Doxorubicin—Vomiting—Triamcinolone—rheumatoid arthritis	2.08e-05	0.000159	CcSEcCtD
Doxorubicin—Vomiting—Methylprednisolone—rheumatoid arthritis	2.08e-05	0.000159	CcSEcCtD
Doxorubicin—Nausea—Hydrocortisone—rheumatoid arthritis	2.07e-05	0.000158	CcSEcCtD
Doxorubicin—Rash—Triamcinolone—rheumatoid arthritis	2.06e-05	0.000158	CcSEcCtD
Doxorubicin—Dermatitis—Triamcinolone—rheumatoid arthritis	2.06e-05	0.000158	CcSEcCtD
Doxorubicin—Anorexia—Methotrexate—rheumatoid arthritis	2.06e-05	0.000158	CcSEcCtD
Doxorubicin—Rash—Methylprednisolone—rheumatoid arthritis	2.06e-05	0.000158	CcSEcCtD
Doxorubicin—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.06e-05	0.000158	CcSEcCtD
Doxorubicin—Urticaria—Prednisone—rheumatoid arthritis	2.06e-05	0.000157	CcSEcCtD
Doxorubicin—Headache—Triamcinolone—rheumatoid arthritis	2.05e-05	0.000157	CcSEcCtD
Doxorubicin—Headache—Methylprednisolone—rheumatoid arthritis	2.05e-05	0.000157	CcSEcCtD
Doxorubicin—Body temperature increased—Prednisone—rheumatoid arthritis	2.04e-05	0.000157	CcSEcCtD
Doxorubicin—Abdominal pain—Prednisone—rheumatoid arthritis	2.04e-05	0.000157	CcSEcCtD
Doxorubicin—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.03e-05	0.000156	CcSEcCtD
Doxorubicin—Diarrhoea—Betamethasone—rheumatoid arthritis	2.03e-05	0.000156	CcSEcCtD
Doxorubicin—Hypotension—Methotrexate—rheumatoid arthritis	2.02e-05	0.000155	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	1.97e-05	0.000151	CcSEcCtD
Doxorubicin—Dizziness—Betamethasone—rheumatoid arthritis	1.96e-05	0.000151	CcSEcCtD
Doxorubicin—Dizziness—Dexamethasone—rheumatoid arthritis	1.96e-05	0.000151	CcSEcCtD
Doxorubicin—Insomnia—Methotrexate—rheumatoid arthritis	1.96e-05	0.00015	CcSEcCtD
Doxorubicin—Nausea—Triamcinolone—rheumatoid arthritis	1.94e-05	0.000149	CcSEcCtD
Doxorubicin—Paraesthesia—Methotrexate—rheumatoid arthritis	1.94e-05	0.000149	CcSEcCtD
Doxorubicin—Nausea—Methylprednisolone—rheumatoid arthritis	1.94e-05	0.000149	CcSEcCtD
Doxorubicin—Dyspnoea—Methotrexate—rheumatoid arthritis	1.93e-05	0.000148	CcSEcCtD
Doxorubicin—Somnolence—Methotrexate—rheumatoid arthritis	1.92e-05	0.000147	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisone—rheumatoid arthritis	1.91e-05	0.000146	CcSEcCtD
Doxorubicin—Dyspepsia—Methotrexate—rheumatoid arthritis	1.9e-05	0.000146	CcSEcCtD
Doxorubicin—Vomiting—Dexamethasone—rheumatoid arthritis	1.89e-05	0.000145	CcSEcCtD
Doxorubicin—Vomiting—Betamethasone—rheumatoid arthritis	1.89e-05	0.000145	CcSEcCtD
Doxorubicin—Decreased appetite—Methotrexate—rheumatoid arthritis	1.88e-05	0.000144	CcSEcCtD
Doxorubicin—Rash—Dexamethasone—rheumatoid arthritis	1.87e-05	0.000144	CcSEcCtD
Doxorubicin—Rash—Betamethasone—rheumatoid arthritis	1.87e-05	0.000144	CcSEcCtD
Doxorubicin—Dermatitis—Betamethasone—rheumatoid arthritis	1.87e-05	0.000143	CcSEcCtD
Doxorubicin—Dermatitis—Dexamethasone—rheumatoid arthritis	1.87e-05	0.000143	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	1.87e-05	0.000143	CcSEcCtD
Doxorubicin—Fatigue—Methotrexate—rheumatoid arthritis	1.86e-05	0.000143	CcSEcCtD
Doxorubicin—Headache—Dexamethasone—rheumatoid arthritis	1.86e-05	0.000143	CcSEcCtD
Doxorubicin—Headache—Betamethasone—rheumatoid arthritis	1.86e-05	0.000143	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisone—rheumatoid arthritis	1.86e-05	0.00683	CbGdCrCtD
Doxorubicin—Asthenia—Prednisone—rheumatoid arthritis	1.86e-05	0.000142	CcSEcCtD
Doxorubicin—Pain—Methotrexate—rheumatoid arthritis	1.85e-05	0.000142	CcSEcCtD
Doxorubicin—Pruritus—Prednisone—rheumatoid arthritis	1.83e-05	0.00014	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisolone—rheumatoid arthritis	1.81e-05	0.00667	CbGdCrCtD
Doxorubicin—Feeling abnormal—Methotrexate—rheumatoid arthritis	1.78e-05	0.000137	CcSEcCtD
Doxorubicin—Diarrhoea—Prednisone—rheumatoid arthritis	1.77e-05	0.000136	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.77e-05	0.000135	CcSEcCtD
Doxorubicin—Nausea—Dexamethasone—rheumatoid arthritis	1.76e-05	0.000135	CcSEcCtD
Doxorubicin—Nausea—Betamethasone—rheumatoid arthritis	1.76e-05	0.000135	CcSEcCtD
Doxorubicin—Urticaria—Methotrexate—rheumatoid arthritis	1.72e-05	0.000132	CcSEcCtD
Doxorubicin—Dizziness—Prednisone—rheumatoid arthritis	1.71e-05	0.000131	CcSEcCtD
Doxorubicin—Body temperature increased—Methotrexate—rheumatoid arthritis	1.71e-05	0.000131	CcSEcCtD
Doxorubicin—Abdominal pain—Methotrexate—rheumatoid arthritis	1.71e-05	0.000131	CcSEcCtD
Doxorubicin—Vomiting—Prednisone—rheumatoid arthritis	1.64e-05	0.000126	CcSEcCtD
Doxorubicin—Rash—Prednisone—rheumatoid arthritis	1.63e-05	0.000125	CcSEcCtD
Doxorubicin—Dermatitis—Prednisone—rheumatoid arthritis	1.63e-05	0.000125	CcSEcCtD
Doxorubicin—Headache—Prednisone—rheumatoid arthritis	1.62e-05	0.000124	CcSEcCtD
Doxorubicin—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.59e-05	0.000122	CcSEcCtD
Doxorubicin—Asthenia—Methotrexate—rheumatoid arthritis	1.55e-05	0.000119	CcSEcCtD
Doxorubicin—Nausea—Prednisone—rheumatoid arthritis	1.54e-05	0.000118	CcSEcCtD
Doxorubicin—Pruritus—Methotrexate—rheumatoid arthritis	1.53e-05	0.000117	CcSEcCtD
Doxorubicin—Diarrhoea—Methotrexate—rheumatoid arthritis	1.48e-05	0.000113	CcSEcCtD
Doxorubicin—Dizziness—Methotrexate—rheumatoid arthritis	1.43e-05	0.00011	CcSEcCtD
Doxorubicin—TOP2A—Norethindrone—Hydrocortisone—rheumatoid arthritis	1.41e-05	0.00517	CbGdCrCtD
Doxorubicin—Vomiting—Methotrexate—rheumatoid arthritis	1.37e-05	0.000105	CcSEcCtD
Doxorubicin—Rash—Methotrexate—rheumatoid arthritis	1.36e-05	0.000104	CcSEcCtD
Doxorubicin—Dermatitis—Methotrexate—rheumatoid arthritis	1.36e-05	0.000104	CcSEcCtD
Doxorubicin—Headache—Methotrexate—rheumatoid arthritis	1.35e-05	0.000104	CcSEcCtD
Doxorubicin—Nausea—Methotrexate—rheumatoid arthritis	1.28e-05	9.84e-05	CcSEcCtD
Doxorubicin—TOP2A—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	1.12e-05	0.00411	CbGdCrCtD
Doxorubicin—CYP2B6—Metabolism—PLB1—rheumatoid arthritis	5.82e-06	6.32e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MTHFR—rheumatoid arthritis	5.8e-06	6.29e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD28—rheumatoid arthritis	5.77e-06	6.26e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.71e-06	6.19e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.69e-06	6.18e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SYK—rheumatoid arthritis	5.69e-06	6.17e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTK2—rheumatoid arthritis	5.62e-06	6.1e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.58e-06	6.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—rheumatoid arthritis	5.57e-06	6.05e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL5—rheumatoid arthritis	5.51e-06	5.98e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT1—rheumatoid arthritis	5.48e-06	5.95e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.46e-06	5.92e-05	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—rheumatoid arthritis	5.45e-06	5.92e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—UBE2D1—rheumatoid arthritis	5.43e-06	5.89e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CSF2—rheumatoid arthritis	5.43e-06	5.89e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CXCL8—rheumatoid arthritis	5.41e-06	5.88e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL10—rheumatoid arthritis	5.41e-06	5.87e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6R—rheumatoid arthritis	5.4e-06	5.86e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MTHFR—rheumatoid arthritis	5.39e-06	5.85e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALOX5—rheumatoid arthritis	5.37e-06	5.82e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.36e-06	5.82e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TYK2—rheumatoid arthritis	5.36e-06	5.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ADRBK1—rheumatoid arthritis	5.26e-06	5.71e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NOS3—rheumatoid arthritis	5.26e-06	5.7e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLD4—rheumatoid arthritis	5.23e-06	5.68e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.19e-06	5.63e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—rheumatoid arthritis	5.17e-06	5.62e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6ST—rheumatoid arthritis	5.12e-06	5.55e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MED1—rheumatoid arthritis	5.11e-06	5.54e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SPP1—rheumatoid arthritis	5.1e-06	5.54e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NOS2—rheumatoid arthritis	5.08e-06	5.51e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ACAN—rheumatoid arthritis	5.05e-06	5.48e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ENO1—rheumatoid arthritis	4.97e-06	5.4e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR5—rheumatoid arthritis	4.96e-06	5.39e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP3—rheumatoid arthritis	4.93e-06	5.35e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLD4—rheumatoid arthritis	4.93e-06	5.35e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD80—rheumatoid arthritis	4.93e-06	5.35e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TYK2—rheumatoid arthritis	4.92e-06	5.34e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MTHFR—rheumatoid arthritis	4.9e-06	5.32e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MMP9—rheumatoid arthritis	4.9e-06	5.32e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2RA—rheumatoid arthritis	4.89e-06	5.31e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.89e-06	5.31e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	4.87e-06	5.29e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PRKCQ—rheumatoid arthritis	4.86e-06	5.27e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—C3—rheumatoid arthritis	4.85e-06	5.26e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.85e-06	5.26e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—rheumatoid arthritis	4.84e-06	5.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOS3—rheumatoid arthritis	4.83e-06	5.24e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	4.83e-06	5.24e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—POMC—rheumatoid arthritis	4.81e-06	5.22e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ENO1—rheumatoid arthritis	4.81e-06	5.22e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—rheumatoid arthritis	4.81e-06	5.22e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT1—rheumatoid arthritis	4.77e-06	5.18e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MAPK8—rheumatoid arthritis	4.76e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CAT—rheumatoid arthritis	4.76e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ACAN—rheumatoid arthritis	4.76e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	4.75e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTK2—rheumatoid arthritis	4.75e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—B3GNT2—rheumatoid arthritis	4.75e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ACP5—rheumatoid arthritis	4.75e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.73e-06	5.13e-05	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.7e-06	5.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL5—rheumatoid arthritis	4.65e-06	5.05e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.65e-06	5.05e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—POMC—rheumatoid arthritis	4.64e-06	5.03e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGES—rheumatoid arthritis	4.62e-06	5.01e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GC—rheumatoid arthritis	4.62e-06	5.01e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—rheumatoid arthritis	4.61e-06	5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—rheumatoid arthritis	4.59e-06	4.98e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CSF2—rheumatoid arthritis	4.58e-06	4.98e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CAT—rheumatoid arthritis	4.57e-06	4.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6R—rheumatoid arthritis	4.57e-06	4.95e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—LEP—rheumatoid arthritis	4.52e-06	4.9e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	4.48e-06	4.86e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—rheumatoid arthritis	4.45e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—rheumatoid arthritis	4.42e-06	4.79e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VEGFA—rheumatoid arthritis	4.4e-06	4.77e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—rheumatoid arthritis	4.38e-06	4.76e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ENO1—rheumatoid arthritis	4.37e-06	4.75e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GC—rheumatoid arthritis	4.35e-06	4.72e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	4.35e-06	4.72e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—POMC—rheumatoid arthritis	4.31e-06	4.68e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SPP1—rheumatoid arthritis	4.31e-06	4.68e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLB1—rheumatoid arthritis	4.29e-06	4.66e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.28e-06	4.64e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—BGN—rheumatoid arthritis	4.27e-06	4.64e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FN1—rheumatoid arthritis	4.26e-06	4.62e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6ST—rheumatoid arthritis	4.24e-06	4.6e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	4.23e-06	4.59e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—rheumatoid arthritis	4.23e-06	4.59e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR5—rheumatoid arthritis	4.19e-06	4.55e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—NOS3—rheumatoid arthritis	4.19e-06	4.55e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TYK2—rheumatoid arthritis	4.16e-06	4.51e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	4.16e-06	4.51e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.14e-06	4.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2RA—rheumatoid arthritis	4.13e-06	4.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—C3—rheumatoid arthritis	4.1e-06	4.45e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	4.09e-06	4.44e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.09e-06	4.44e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CD80—rheumatoid arthritis	4.08e-06	4.43e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	4.05e-06	4.39e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NOS3—rheumatoid arthritis	4.05e-06	4.39e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—rheumatoid arthritis	4.04e-06	4.38e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTHFR—rheumatoid arthritis	3.98e-06	4.31e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALOX5—rheumatoid arthritis	3.93e-06	4.27e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—rheumatoid arthritis	3.93e-06	4.27e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—POMC—rheumatoid arthritis	3.92e-06	4.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—POMC—rheumatoid arthritis	3.88e-06	4.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	3.84e-06	4.17e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—rheumatoid arthritis	3.83e-06	4.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LEP—rheumatoid arthritis	3.82e-06	4.14e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—rheumatoid arthritis	3.81e-06	4.14e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTHFR—rheumatoid arthritis	3.81e-06	4.14e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL2—rheumatoid arthritis	3.8e-06	4.12e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6R—rheumatoid arthritis	3.78e-06	4.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MED1—rheumatoid arthritis	3.77e-06	4.09e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NOS3—rheumatoid arthritis	3.76e-06	4.08e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—rheumatoid arthritis	3.76e-06	4.08e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—rheumatoid arthritis	3.73e-06	4.05e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—rheumatoid arthritis	3.7e-06	4.02e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CCR5—rheumatoid arthritis	3.65e-06	3.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FN1—rheumatoid arthritis	3.6e-06	3.9e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6ST—rheumatoid arthritis	3.58e-06	3.89e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CAT—rheumatoid arthritis	3.58e-06	3.88e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—rheumatoid arthritis	3.57e-06	3.88e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTHFR—rheumatoid arthritis	3.57e-06	3.87e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HLA-A—rheumatoid arthritis	3.56e-06	3.86e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MED1—rheumatoid arthritis	3.55e-06	3.85e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	3.52e-06	3.82e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ACP5—rheumatoid arthritis	3.5e-06	3.8e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	3.5e-06	3.8e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—rheumatoid arthritis	3.48e-06	3.77e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—rheumatoid arthritis	3.47e-06	3.77e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CAT—rheumatoid arthritis	3.46e-06	3.76e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD80—rheumatoid arthritis	3.45e-06	3.74e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TYK2—rheumatoid arthritis	3.45e-06	3.74e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—rheumatoid arthritis	3.44e-06	3.73e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOS3—rheumatoid arthritis	3.38e-06	3.67e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—rheumatoid arthritis	3.32e-06	3.61e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	3.3e-06	3.58e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	3.3e-06	3.58e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	3.29e-06	3.57e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—POMC—rheumatoid arthritis	3.28e-06	3.56e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	3.22e-06	3.5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL2—rheumatoid arthritis	3.21e-06	3.48e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ENO1—rheumatoid arthritis	3.21e-06	3.48e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6R—rheumatoid arthritis	3.2e-06	3.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—rheumatoid arthritis	3.19e-06	3.47e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—POMC—rheumatoid arthritis	3.18e-06	3.45e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BGN—rheumatoid arthritis	3.15e-06	3.42e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CAT—rheumatoid arthritis	3.15e-06	3.42e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—rheumatoid arthritis	3.13e-06	3.39e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6ST—rheumatoid arthritis	3.12e-06	3.38e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	3.11e-06	3.38e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS2—rheumatoid arthritis	3.09e-06	3.36e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—POMC—rheumatoid arthritis	3.05e-06	3.31e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—rheumatoid arthritis	3.04e-06	3.3e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD80—rheumatoid arthritis	3e-06	3.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL8—rheumatoid arthritis	3e-06	3.26e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTHFR—rheumatoid arthritis	2.99e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BGN—rheumatoid arthritis	2.97e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	2.93e-06	3.18e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TYK2—rheumatoid arthritis	2.91e-06	3.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	2.9e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	2.9e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—rheumatoid arthritis	2.9e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTHFR—rheumatoid arthritis	2.89e-06	3.13e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—rheumatoid arthritis	2.87e-06	3.11e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	2.85e-06	3.09e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GC—rheumatoid arthritis	2.85e-06	3.09e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6R—rheumatoid arthritis	2.78e-06	3.02e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—rheumatoid arthritis	2.78e-06	3.02e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NOS3—rheumatoid arthritis	2.77e-06	3.01e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	2.73e-06	2.97e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MMP9—rheumatoid arthritis	2.71e-06	2.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—rheumatoid arthritis	2.7e-06	2.93e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NFKB1—rheumatoid arthritis	2.69e-06	2.91e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NOS3—rheumatoid arthritis	2.66e-06	2.88e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	2.65e-06	2.87e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK8—rheumatoid arthritis	2.64e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—rheumatoid arthritis	2.63e-06	2.85e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—rheumatoid arthritis	2.62e-06	2.84e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—rheumatoid arthritis	2.54e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—rheumatoid arthritis	2.54e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TYK2—rheumatoid arthritis	2.53e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS3—rheumatoid arthritis	2.49e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—rheumatoid arthritis	2.44e-06	2.64e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—rheumatoid arthritis	2.43e-06	2.64e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—rheumatoid arthritis	2.42e-06	2.63e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—rheumatoid arthritis	2.41e-06	2.61e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—rheumatoid arthritis	2.39e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ENO1—rheumatoid arthritis	2.36e-06	2.57e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.32e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—rheumatoid arthritis	2.31e-06	2.51e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAT—rheumatoid arthritis	2.31e-06	2.5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—rheumatoid arthritis	2.29e-06	2.49e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—rheumatoid arthritis	2.29e-06	2.49e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—rheumatoid arthritis	2.27e-06	2.47e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NFKB1—rheumatoid arthritis	2.27e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—rheumatoid arthritis	2.24e-06	2.43e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK8—rheumatoid arthritis	2.23e-06	2.42e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	2.23e-06	2.42e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.21e-06	2.4e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—rheumatoid arthritis	2.18e-06	2.36e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.16e-06	2.34e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.16e-06	2.34e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—rheumatoid arthritis	2.11e-06	2.29e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—rheumatoid arthritis	2.1e-06	2.28e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—rheumatoid arthritis	2.08e-06	2.26e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—rheumatoid arthritis	2.06e-06	2.23e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—rheumatoid arthritis	2.03e-06	2.21e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—rheumatoid arthritis	2.01e-06	2.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.94e-06	2.11e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—rheumatoid arthritis	1.93e-06	2.09e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—rheumatoid arthritis	1.92e-06	2.08e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—rheumatoid arthritis	1.91e-06	2.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.89e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—rheumatoid arthritis	1.84e-06	2e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—rheumatoid arthritis	1.84e-06	2e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—rheumatoid arthritis	1.83e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.79e-06	1.94e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAT—rheumatoid arthritis	1.7e-06	1.85e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—rheumatoid arthritis	1.69e-06	1.83e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	1.68e-06	1.82e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—rheumatoid arthritis	1.64e-06	1.78e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.6e-06	1.74e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—rheumatoid arthritis	1.56e-06	1.69e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—rheumatoid arthritis	1.54e-06	1.67e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.46e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—rheumatoid arthritis	1.42e-06	1.55e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	1.42e-06	1.54e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—rheumatoid arthritis	1.4e-06	1.52e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—rheumatoid arthritis	1.34e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.34e-06	1.45e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—rheumatoid arthritis	1.24e-06	1.34e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—rheumatoid arthritis	1.23e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.14e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.07e-06	1.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.05e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—rheumatoid arthritis	1.04e-06	1.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—rheumatoid arthritis	9.91e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—rheumatoid arthritis	9.76e-07	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	9.34e-07	1.01e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	9.06e-07	9.84e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	8.75e-07	9.5e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	8.54e-07	9.27e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—rheumatoid arthritis	7e-07	7.6e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—rheumatoid arthritis	6.38e-07	6.93e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	6.1e-07	6.63e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	5.58e-07	6.06e-06	CbGpPWpGaD
